Clinical Trials Directory

Trials / Completed

CompletedNCT03396120

The FVC/DLCO Ratio is a Useful Predictor of Pulmonary Hypertension in Patients With Interstitial Lung Disease

Status
Completed
Phase
Study type
Observational
Enrollment
95 (actual)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Pulmonary hypertension (PH) is a common disorder among patients with interstitial lung disease (ILD). The symptoms are usually nonspecific and overlooked. Thus, a noninvasive screening modality is recommended for early detection of PH because of its potentially significant impact on treatment strategy and clinical outcomes. Objectives: To evaluate the usefulness of assessing forced vital capacity (FVC%), diffusion capacity of the lung for carbon monoxide (DLCO%), and FVC%/DLCO% ratio to predict pulmonary hypertension among patients with ILDs.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPulmonary function testforced vital capacity and diffusing capacity

Timeline

Start date
2017-02-02
Primary completion
2017-12-01
Completion
2017-12-31
First posted
2018-01-10
Last updated
2018-01-10

Locations

2 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03396120. Inclusion in this directory is not an endorsement.

The FVC/DLCO Ratio is a Useful Predictor of Pulmonary Hypertension in Patients With Interstitial Lung Disease (NCT03396120) · Clinical Trials Directory